88 results
Page 4 of 5
8-K
EX-99.1
17dbc 46vkibi43ou7tg
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.2
dowxx5lix7q4l
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
qwwa knun
20 Jul 21
Regulation FD Disclosure
8:36am
8-K
EX-99.1
g1p1r85nrze5x93c
17 Jun 21
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D. to Board of Directors
4:55pm
8-K
EX-99.1
4v55sky
20 May 21
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
9:07am
8-K
EX-99.1
a7nnr10c
12 May 21
Immunome Reports First Quarter 2021 Financial Results
6:05am
8-K
EX-99.1
98hlk6fbh5
26 Apr 21
Regulation FD Disclosure
6:07am
8-K
9z1tlakz0a yohn1me
26 Apr 21
Regulation FD Disclosure
6:07am
8-K
EX-99.1
n9ecdomc6a0toy168eb
26 Apr 21
Immunome Announces $27 Million Private Placement
6:05am
DEF 14A
x8gzo9 z408e
16 Apr 21
Definitive proxy
3:35pm
8-K
EX-99.1
hp2vj7qa
29 Mar 21
Regulation FD Disclosure
6:02am
8-K
6zeqrgr
29 Mar 21
Regulation FD Disclosure
6:02am
8-K
EX-99.1
fvz6 xzo1z
25 Mar 21
Immunome Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update
5:30pm
10-K
53shji
25 Mar 21
Annual report
5:01pm
8-K
EX-99.1
d1cb09jn fi54iaqwo
16 Mar 21
Regulation FD Disclosure
6:00am
8-K
l86pttqktnvohmoss
16 Mar 21
Regulation FD Disclosure
6:00am
8-K
EX-99.1
rc44nyv4byshbk3
17 Nov 20
Immunome Reports Third Quarter 2020 Financial Results and Significant Progress
5:18pm
10-Q
qwn3l3404wag rnl3dj4
16 Nov 20
Quarterly report
4:43pm